1. Home
  2. RGEN vs WAY Comparison

RGEN vs WAY Comparison

Compare RGEN & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • WAY
  • Stock Information
  • Founded
  • RGEN 1981
  • WAY 1999
  • Country
  • RGEN United States
  • WAY United States
  • Employees
  • RGEN N/A
  • WAY N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • WAY
  • Sector
  • RGEN Health Care
  • WAY
  • Exchange
  • RGEN Nasdaq
  • WAY Nasdaq
  • Market Cap
  • RGEN 8.0B
  • WAY 6.8B
  • IPO Year
  • RGEN N/A
  • WAY 2024
  • Fundamental
  • Price
  • RGEN $118.07
  • WAY $39.98
  • Analyst Decision
  • RGEN Buy
  • WAY Strong Buy
  • Analyst Count
  • RGEN 12
  • WAY 12
  • Target Price
  • RGEN $172.67
  • WAY $41.45
  • AVG Volume (30 Days)
  • RGEN 791.0K
  • WAY 2.0M
  • Earning Date
  • RGEN 04-29-2025
  • WAY 04-30-2025
  • Dividend Yield
  • RGEN N/A
  • WAY N/A
  • EPS Growth
  • RGEN N/A
  • WAY N/A
  • EPS
  • RGEN N/A
  • WAY 0.15
  • Revenue
  • RGEN $650,429,000.00
  • WAY $975,192,000.00
  • Revenue This Year
  • RGEN $13.93
  • WAY $8.84
  • Revenue Next Year
  • RGEN $14.35
  • WAY $9.35
  • P/E Ratio
  • RGEN N/A
  • WAY $260.84
  • Revenue Growth
  • RGEN 4.88
  • WAY 18.25
  • 52 Week Low
  • RGEN $102.97
  • WAY $20.26
  • 52 Week High
  • RGEN $182.52
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.80
  • WAY N/A
  • Support Level
  • RGEN $120.55
  • WAY N/A
  • Resistance Level
  • RGEN $123.71
  • WAY N/A
  • Average True Range (ATR)
  • RGEN 4.63
  • WAY 0.00
  • MACD
  • RGEN -0.58
  • WAY 0.00
  • Stochastic Oscillator
  • RGEN 7.59
  • WAY 0.00

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: